Belluscura was established in the U.K. as a medical device company focused on developing oxygen enrichment technology to help improve health for Chronic Obstructive Pulmonary Disease (COPD) patients and more favorable economic outcomes for the patient, provider, and insurance companies. COPD is the third leading cause of death in the United States, affecting approximately 30 million people in the U.S. and over 100 million worldwide. Belluscura, now with North American headquarters located in Texas, is dedicated to developing proprietary, patented oxygen enrichment technologies that can be applied across a range of treatment possibilities and positively impact millions of people across the globe.
Company Details
- Employees
- 31
- Founded
- -
- Address
- Plano, Texas 75024, Us
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.belluscura.com
- HQ
- Plano, Texas
Belluscura Questions
Belluscura's website is https://www.belluscura.com
Belluscura's LinkedIn profile is https://www.linkedin.com/company/belluscura
Belluscura has
31 employees.
View email and phone details for 31
employees at Belluscura.
Belluscura's industry is
Medical Equipment Manufacturing
Belluscura's top competitors are
Smith+nephew,
Argon Medical Devices, Inc.,
Cleanis® Inc,
Oximedical Respiratory,
Novo Med Spa,
Dowgate Capital,
Inogen,
Sirtex Medical Limited,
O2 Concepts,
Caire Inc..
Belluscura's categories are Medical Equipment Manufacturing
Belluscura's founding year is 2016
